AKUMS - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 4.0

💊 AKUMS shows strong volume, technical support, and improving profitability — a favorable setup for intraday trading with moderate risk.

📈 Positive

• 🔹 MACD at 1.40: Bullish crossover indicates positive short-term momentum.
• 🔹 RSI at 56.3: In bullish-neutral territory, suggesting room for further upside.
• 🔹 Price at 50 DMA: Current price (₹471) is aligned with 50 DMA (₹470), offering a pivot level.
• 🔹 Volume Surge: Current volume (2.24L) is more than double the 1-week average (1.07L), indicating strong intraday interest.
• 🔹 Low Debt: Debt-to-equity ratio of 0.02 reflects a healthy balance sheet.

⚠️ Limitation

• 🔸 Price Below 200 DMA: Current price is under 200 DMA (₹534), indicating long-term resistance.
• 🔸 High P/E Ratio: At 45.2, above industry average (33.1), suggesting premium valuation.
• 🔸 FII Outflow: Foreign institutional holdings declined by 1.97%.
• 🔸 52-Week Index at 14.9%: Indicates underperformance relative to its 52-week high.

🚫 Company Negative News

• 📉 Valuation Concerns: Analysts cautious about high P/E amid modest earnings growth.

✅ Company Positive News

• 💊 Profit Growth: PAT rose from ₹27.6 Cr to ₹44.9 Cr, a 7.14% quarterly improvement.
• 📈 Institutional Support: DII holdings increased by 0.43%, signaling domestic confidence.

🏦 Industry

• 🧪 Sector: Pharmaceuticals — Contract Manufacturing & Formulations.
• 📊 Industry PE: 33.1, lower than AKUMS’ P/E, suggesting valuation caution.

📌 Conclusion

• 📉 Intraday Setup: Strong volume and MACD favor upside; ideal for momentum-based trades with valuation caution.
• 💰 Optimal Buy Price: ₹466–₹470 (near 50 DMA support).
• 📈 Profit Exit Level: ₹480–₹488 (short-term resistance zone).
• 🛑 Stop Loss: ₹458 (below recent support).
• ⏳ If Holding: Exit if RSI dips below 54 or price fails to hold above ₹468 intraday.

I can also compare AKUMS’ intraday setup with other mid-cap pharma stocks showing similar volume breakouts.